These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1344592

  • 21. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, Watanabe K, Gabazza EC, Kurokawa I, Mizutani H.
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [Abstract] [Full Text] [Related]

  • 22. Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation.
    Hsu C, Tsai TH, Li YY, Wu WH, Huang CJ, Tsai PJ.
    Food Chem; 2012 Dec 01; 135(3):976-84. PubMed ID: 22953813
    [Abstract] [Full Text] [Related]

  • 23. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Dec 01; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 24. Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes.
    Tanaka M, Suda T, Yatomi T, Nakamura N, Nagata S.
    J Immunol; 1997 Mar 01; 158(5):2303-9. PubMed ID: 9036978
    [Abstract] [Full Text] [Related]

  • 25. [Evaluation of immunostimulation of sheep with Propionibacterium acnes strain CN 5936 in the prevention of listeriosis].
    Furowicz A, Zyska W, Czernomysy-Furowicz D, Pawiński J.
    Pol Arch Weter; 1990 Mar 01; 30(3-4):125-40. PubMed ID: 2132654
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W.
    Arch Immunol Ther Exp (Warsz); 1982 Mar 01; 30(5-6):379-84. PubMed ID: 7184489
    [Abstract] [Full Text] [Related]

  • 30. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes.
    Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heit A, Akira S, Galanos C, Freudenberg MA.
    J Immunol; 2005 Apr 01; 174(7):4295-300. PubMed ID: 15778393
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Studies on pathogenicity and persistence of Propionibacterium acnes in mice.
    Abe C, Homma Y, Ueda K, Saegusa J, Nakayama M.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec 01; 251(2):223-9. PubMed ID: 7200303
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA, Cohen RJ, Garrett KL.
    BJU Int; 2008 Feb 01; 101(4):429-35. PubMed ID: 17850358
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
    Mathé G, Kamel M, Dezfulian M, Halle-Pannenko O, Bourut C.
    Cancer Res; 1973 Sep 01; 33(9):1987-97. PubMed ID: 4146853
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.